Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions

NCT06987773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: RLF-OD032 100 mg/mL oral suspension
DRUG: Kuvan 100 MG Powder for Oral Solution

Sponsor

APR Applied Pharma Research s.a.